RC-552

RC-552 is a novel synthetic glycolipid related in chemical structure to MLA. RC-552 induces delayed cardioprotective effects via an iNOS-dependent pathway. RC-552 attenuates myocardial stunning[1][2].

Product Specifications

CAS Number

253119-91-4

UNSPSC

12352005

Target

NO Synthase

Related Pathways

Immunology/Inflammation

Field of Research

Cardiovascular Disease

Smiles

CCCCCCCCCCCCCC(O[C@H](CCCCCCCCCCC)CC(O[C@@H]1[C@H]([C@@H](O[C@H](CO)[C@H]1OP(O)(O)=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)NC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCCCCCC)=O)=O)NC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCCCCCCCC)=O)=O)=O)=O

Molecular Formula

C102H193N2O21P

Molecular Weight

1814.60

References & Citations

[1]Elliott GT, et al. The novel glycolipid RC-552 attenuates myocardial stunning and reduces infarct size in dogs. J Mol Cell Cardiol. 2000 Jul;32 (7) :1327-39. |[2]Xi L, et al. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice. Am J Physiol. 1999 Dec;277 (6) :H2418-24.